According to data obtained under the RTI Act, the AIIMS-Delhi got more than Rs 23 crore in funding from the Centre for the treatment of uncommon diseases during the course of the previous five years. According to data obtained through the right...
The National Health Authority (NHA) has started the 100 Microsites Project under the Ayushman Bharat Digital Mission (ABDM) in order to increase digital health adoption and thereby make healthcare more accessible to all...
The London-listed company, which reports earnings in US dollars, reported an adjusted profit of $2.15 per share on sales of approximately $11.42 billion. According to sources, analysts were expecting $1.98 per share on sales...
Manipal Hospital in Vijayawada has taken a significant step forward in medical technology with the introduction of the cutting-edge 4th Gen Da Vinci X robotic-assisted surgery unit...
Asprius Lifesciences, a Gujarat-based pharmaceutical company, has announced the development of a treatment for Diabetic Neuropathy, a condition that causes nerve damage in the body's peripheral areas. The company stated that it has already filed...
The pharmaceutical business has always been at the forefront of technical breakthroughs, trying to better medication development procedures and, eventually, patient results.
Sonali Bendre has been named as FUJIFILM India's brand ambassador for breast cancer screening advocacy. Sonali Bendre's incredible journey of resilience and determination has made her a powerful voice in the fight against cancer,...
As per to Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance, India should try to reach an agreement with Australia to use the Pharmaceutical Benefit Scheme (PBS) for the selection, listing, and pricing of exported medicines. ..
Akums Drugs and Pharmaceuticals Limited's triple combination diabetic treatment has been approved. Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 are more advanced diabetes treatments with far more efficacy and precision...
Moderna announced the start of patient enrollment in a late-stage study evaluating its tailored mRNA-based skin cancer vaccine in combination with Merck's blockbuster medication Keytruda. A mid-stage research found that the combination...
, CDSCO.jpg)
